Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,203.20
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.75
(
-0.44%
)
Bitcoin
77,701.59
(
-0.74%
)
News Focus
News Focus
Post# of 257442
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122884
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 192323

Friday, 07/24/2015 10:00:25 AM

Friday, July 24, 2015 10:00:25 AM

Post# of 257442
SNY/REGN—CHMP approves Praluent (PCSK9):

http://www.reuters.com/article/2015/07/24/us-sanofi-regeneron-cholesterol-idUSKCN0PY18L20150724

The indication is: i) patients unable to control their cholesterol despite taking optimal doses of a statin; or ii) patients who are statin-intolerant.

The EU Commission will rubber stamp the CHMP decision in 2-3 months.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today